BRIEF published on 02/27/2025 at 12:41, 1 year 8 months ago ECJ Ruling Impacts DocMorris Advertising Strategy DocMorris AG ECJ Ruling Prescription Medicine Discounts German Court Case Advertising Regulations
PRESS RELEASE published on 02/27/2025 at 12:36, 1 year 8 months ago DocMorris AG: ECJ Ruling on advertising for prescription medicines DocMorris AG: ECJ ruling permits Rx discount promotions with vouchers for beauty and personal care products. Company to focus on digitalization and e-prescriptions growth in Germany Digitalization DocMorris AG ECJ Ruling Prescription Medicines Discount Promotions
BRIEF published on 01/21/2025 at 07:03, 1 year 9 months ago DocMorris Reports 6.7% Growth in 2024 with Strong Rx Revenue Surge 2024 Financial Results DocMorris Growth Rx Revenue Increase TeleClinic Performance German Market Trends
PRESS RELEASE published on 01/21/2025 at 06:58, 1 year 9 months ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter DocMorris grows 6.7% in 2024 with increased Rx sales, OTC revenues and TeleClinic profits. Achieved revenue target and positive cash position. Outlook confirmed for 2024 Revenue Growth DocMorris Rx Sales TeleClinic OTC Revenues
BRIEF published on 10/15/2024 at 07:03, 2 years ago DocMorris Accelerates Prescription Medicine Growth Revenue Growth Telehealth DocMorris AG Prescription Medicine Logistics Closure
PRESS RELEASE published on 10/15/2024 at 06:58, 2 years ago DocMorris accelerates Rx growth DocMorris accelerates Rx growth with a 12.2% revenue increase in Q3, new CTO appointed, and logistics site closure in Germany. Strong growth in e-prescriptions and customer base E-prescriptions DocMorris CTO Appointment Rx Growth Logistics Site Closure
BRIEF published on 08/20/2024 at 07:03, 2 years 2 months ago DocMorris Enhances Prescription Business and Boosts New Rx Customer Investment 2024 Outlook E-prescriptions DocMorris Prescription Business TeleClinic
PRESS RELEASE published on 08/20/2024 at 06:58, 2 years 2 months ago DocMorris grows in the prescription business and invests incrementally in new Rx customers DocMorris reports growth in prescription business and increased investments in new Rx customers. Break-even reached, outlook for 2024 adjusted due to e-prescription transition Financial Results E-prescriptions New Customers DocMorris Prescription Business
BRIEF published on 07/11/2024 at 07:03, 2 years 3 months ago DocMorris Reports Significant eRx Growth in Q2 2024 Revenue Increase Market Expansion DocMorris ERx Growth
PRESS RELEASE published on 07/11/2024 at 06:58, 2 years 3 months ago DocMorris with accelerated and significant eRx growth in new customers, market share and revenue DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base Revenue Market Share DocMorris ERx Growth CardLink
Published on 10/30/2026 at 23:35, 1 day 3 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 3 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 8 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 11 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 10 hours 49 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 4 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 8 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 4 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 15 hours ago Capital increase through exercise of subscription rights
